NSAIDs including ibuprofen, naproxen sodium, and diclofenac, when prescribed at full therapeutic doses, are more effective analgesics than single-entity immediate-release opioid formulations of codeine, oxycodone, or morphine for treating pain after the surgical removal of impacted third molar teeth.
The global Dental NSAIDs market was valued at US$ 398 million in 2023 and is anticipated to reach US$ 614.8 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dental NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dental NSAIDs.
Report Scope
The Dental NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dental NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dental NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Sunstar
Colgate-Palmolive
DenMat
Showa Yakuhin Kako
Bausch Health
Segment by Type
Injection Type
Oral Type
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dental NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dental NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Dental NSAIDs Market Overview
1.1 Product Overview and Scope of Dental NSAIDs
1.2 Dental NSAIDs Segment by Type
1.2.1 Global Dental NSAIDs Market Value Comparison by Type (2024-2030)
1.2.2 Injection Type
1.2.3 Oral Type
1.2.4 Others
1.3 Dental NSAIDs Segment by Application
1.3.1 Global Dental NSAIDs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dental NSAIDs Market Size Estimates and Forecasts
1.4.1 Global Dental NSAIDs Revenue 2019-2030
1.4.2 Global Dental NSAIDs Sales 2019-2030
1.4.3 Global Dental NSAIDs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dental NSAIDs Market Competition by Manufacturers
2.1 Global Dental NSAIDs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dental NSAIDs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dental NSAIDs Average Price by Manufacturers (2019-2024)
2.4 Global Dental NSAIDs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dental NSAIDs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dental NSAIDs, Product Type & Application
2.7 Dental NSAIDs Market Competitive Situation and Trends
2.7.1 Dental NSAIDs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dental NSAIDs Players Market Share by Revenue
2.7.3 Global Dental NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dental NSAIDs Retrospective Market Scenario by Region
3.1 Global Dental NSAIDs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dental NSAIDs Global Dental NSAIDs Sales by Region: 2019-2030
3.2.1 Global Dental NSAIDs Sales by Region: 2019-2024
3.2.2 Global Dental NSAIDs Sales by Region: 2025-2030
3.3 Global Dental NSAIDs Global Dental NSAIDs Revenue by Region: 2019-2030
3.3.1 Global Dental NSAIDs Revenue by Region: 2019-2024
3.3.2 Global Dental NSAIDs Revenue by Region: 2025-2030
3.4 North America Dental NSAIDs Market Facts & Figures by Country
3.4.1 North America Dental NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dental NSAIDs Sales by Country (2019-2030)
3.4.3 North America Dental NSAIDs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dental NSAIDs Market Facts & Figures by Country
3.5.1 Europe Dental NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dental NSAIDs Sales by Country (2019-2030)
3.5.3 Europe Dental NSAIDs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dental NSAIDs Market Facts & Figures by Country
3.6.1 Asia Pacific Dental NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dental NSAIDs Sales by Country (2019-2030)
3.6.3 Asia Pacific Dental NSAIDs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dental NSAIDs Market Facts & Figures by Country
3.7.1 Latin America Dental NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dental NSAIDs Sales by Country (2019-2030)
3.7.3 Latin America Dental NSAIDs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dental NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa Dental NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dental NSAIDs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dental NSAIDs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dental NSAIDs Sales by Type (2019-2030)
4.1.1 Global Dental NSAIDs Sales by Type (2019-2024)
4.1.2 Global Dental NSAIDs Sales by Type (2025-2030)
4.1.3 Global Dental NSAIDs Sales Market Share by Type (2019-2030)
4.2 Global Dental NSAIDs Revenue by Type (2019-2030)
4.2.1 Global Dental NSAIDs Revenue by Type (2019-2024)
4.2.2 Global Dental NSAIDs Revenue by Type (2025-2030)
4.2.3 Global Dental NSAIDs Revenue Market Share by Type (2019-2030)
4.3 Global Dental NSAIDs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dental NSAIDs Sales by Application (2019-2030)
5.1.1 Global Dental NSAIDs Sales by Application (2019-2024)
5.1.2 Global Dental NSAIDs Sales by Application (2025-2030)
5.1.3 Global Dental NSAIDs Sales Market Share by Application (2019-2030)
5.2 Global Dental NSAIDs Revenue by Application (2019-2030)
5.2.1 Global Dental NSAIDs Revenue by Application (2019-2024)
5.2.2 Global Dental NSAIDs Revenue by Application (2025-2030)
5.2.3 Global Dental NSAIDs Revenue Market Share by Application (2019-2030)
5.3 Global Dental NSAIDs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Dental NSAIDs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Dental NSAIDs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 JandJ
6.3.1 JandJ Corporation Information
6.3.2 JandJ Description and Business Overview
6.3.3 JandJ Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 JandJ Dental NSAIDs Product Portfolio
6.3.5 JandJ Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK Dental NSAIDs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Septodont
6.5.1 Septodont Corporation Information
6.5.2 Septodont Description and Business Overview
6.5.3 Septodont Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Septodont Dental NSAIDs Product Portfolio
6.5.5 Septodont Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Dental NSAIDs Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 PerioChip
6.6.1 PerioChip Corporation Information
6.6.2 PerioChip Description and Business Overview
6.6.3 PerioChip Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PerioChip Dental NSAIDs Product Portfolio
6.7.5 PerioChip Recent Developments/Updates
6.8 Sunstar
6.8.1 Sunstar Corporation Information
6.8.2 Sunstar Description and Business Overview
6.8.3 Sunstar Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sunstar Dental NSAIDs Product Portfolio
6.8.5 Sunstar Recent Developments/Updates
6.9 Colgate-Palmolive
6.9.1 Colgate-Palmolive Corporation Information
6.9.2 Colgate-Palmolive Description and Business Overview
6.9.3 Colgate-Palmolive Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Colgate-Palmolive Dental NSAIDs Product Portfolio
6.9.5 Colgate-Palmolive Recent Developments/Updates
6.10 DenMat
6.10.1 DenMat Corporation Information
6.10.2 DenMat Description and Business Overview
6.10.3 DenMat Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 DenMat Dental NSAIDs Product Portfolio
6.10.5 DenMat Recent Developments/Updates
6.11 Showa Yakuhin Kako
6.11.1 Showa Yakuhin Kako Corporation Information
6.11.2 Showa Yakuhin Kako Dental NSAIDs Description and Business Overview
6.11.3 Showa Yakuhin Kako Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Showa Yakuhin Kako Dental NSAIDs Product Portfolio
6.11.5 Showa Yakuhin Kako Recent Developments/Updates
6.12 Bausch Health
6.12.1 Bausch Health Corporation Information
6.12.2 Bausch Health Dental NSAIDs Description and Business Overview
6.12.3 Bausch Health Dental NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bausch Health Dental NSAIDs Product Portfolio
6.12.5 Bausch Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dental NSAIDs Industry Chain Analysis
7.2 Dental NSAIDs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dental NSAIDs Production Mode & Process
7.4 Dental NSAIDs Sales and Marketing
7.4.1 Dental NSAIDs Sales Channels
7.4.2 Dental NSAIDs Distributors
7.5 Dental NSAIDs Customers
8 Dental NSAIDs Market Dynamics
8.1 Dental NSAIDs Industry Trends
8.2 Dental NSAIDs Market Drivers
8.3 Dental NSAIDs Market Challenges
8.4 Dental NSAIDs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Sunstar
Colgate-Palmolive
DenMat
Showa Yakuhin Kako
Bausch Health
*If Applicable.